# Intensity Modulated Radiation Therapy for Prostate Cancer

> **NCT00214422** · EARLY_PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 19 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT00214422
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09-19
- **Primary completion:** 2014-05-27
- **Final completion:** 2018-04-18
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2019-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214422, "Intensity Modulated Radiation Therapy for Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00214422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*